---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-184625"
form_type: "8-K"
ticker: "SRPT"
cik: "0000873303"
company_name: "Sarepta Therapeutics, Inc."
filed_at: "2025-08-21T23:59:59+00:00"
generated_at: "2026-05-17T11:00:33.864338+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sarepta exchanges $700M of 1.25% notes due 2027 for new 4.875% notes due 2030, stock, and cash

## Summary
- Exchanged ~$700M existing 1.25% convertible notes for $602M new 4.875% notes due 2030, $110M stock, and ~$123.3M cash.
- New notes conversion price ~$60/share, representing a 191.5% premium over the $20.58 Aug 20 closing price.
- Private placement of $20M common stock to J. Wood Capital Advisors at price with floor of $14.41/share.
- Up to 835,765 fee shares may be issued to J. Wood Capital Advisors for advisory services.
- Exchange expected to close Aug 28, 2025, subject to customary closing conditions.

## SEC filing metadata
- accession: 0001193125-25-184625
- form_type: 8-K
- ticker: SRPT
- cik: 0000873303
- company_name: Sarepta Therapeutics, Inc.
- filed_at: 2025-08-21T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/873303/000119312525184625/0001193125-25-184625-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/873303/000119312525184625/d938350d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-184625
- JSON: https://secwatch.observer/filing/0001193125-25-184625.json
- Plain text: https://secwatch.observer/filing/0001193125-25-184625.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.